László Havas

987 total citations
20 papers, 646 citations indexed

About

László Havas is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, László Havas has authored 20 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in László Havas's work include Neuroscience and Neuropharmacology Research (4 papers), Alzheimer's disease research and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). László Havas is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Alzheimer's disease research and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). László Havas collaborates with scholars based in Hungary, Germany and United Kingdom. László Havas's co-authors include Thomas A. Bayer, Peter Falkai, Rolf Buslei, Katalin Majtényi, József I. Engelhardt, László Siklós, Judit Soós, Konrad Beyreuther, Zsófia Maglóczky and Tobias Hartmann and has published in prestigious journals such as Science, Nature Neuroscience and Antimicrobial Agents and Chemotherapy.

In The Last Decade

László Havas

17 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Havas Hungary 11 207 188 173 146 137 20 646
Daniela Elgueta Chile 10 471 2.3× 219 1.2× 222 1.3× 215 1.5× 202 1.5× 12 919
Olga N. Chernyshev United States 10 274 1.3× 126 0.7× 108 0.6× 49 0.3× 119 0.9× 11 574
Robert A. Angel United States 7 222 1.1× 124 0.7× 279 1.6× 45 0.3× 136 1.0× 9 598
Christina S. Hines United States 15 104 0.5× 105 0.6× 247 1.4× 41 0.3× 325 2.4× 17 841
Dominique Demeyer France 14 187 0.9× 86 0.5× 262 1.5× 85 0.6× 316 2.3× 24 906
Lilah Toker Israel 16 97 0.5× 98 0.5× 200 1.2× 156 1.1× 307 2.2× 27 757
Kinga Woźniak United States 17 51 0.2× 78 0.4× 372 2.2× 74 0.5× 233 1.7× 37 782
Gianna Fote United States 10 247 1.2× 198 1.1× 183 1.1× 35 0.2× 278 2.0× 25 843
Young Cheul Chung South Korea 13 441 2.1× 107 0.6× 232 1.3× 296 2.0× 224 1.6× 20 911
Hikaru Ito Japan 15 114 0.6× 120 0.6× 224 1.3× 59 0.4× 586 4.3× 37 896

Countries citing papers authored by László Havas

Since Specialization
Citations

This map shows the geographic impact of László Havas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Havas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Havas more than expected).

Fields of papers citing papers by László Havas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Havas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Havas. The network helps show where László Havas may publish in the future.

Co-authorship network of co-authors of László Havas

This figure shows the co-authorship network connecting the top 25 collaborators of László Havas. A scholar is included among the top collaborators of László Havas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Havas. László Havas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szocsics, Péter, et al.. (2023). Interhemispheric differences of pyramidal cells in the primary motor cortices of schizophrenia patients investigated postmortem. Cerebral Cortex. 33(13). 8179–8193. 2 indexed citations
2.
Szocsics, Péter, et al.. (2020). Perisomatic innervation and neurochemical features of giant pyramidal neurons in both hemispheres of the human primary motor cortex. Brain Structure and Function. 226(1). 281–296. 10 indexed citations
3.
Ádori, Csaba, Laura Glück, Swapnali Barde, et al.. (2015). Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease. Acta Neuropathologica. 129(4). 541–563. 32 indexed citations
4.
Giber, Kristóf, Marco A. Diana, Viktor Plattner, et al.. (2015). A subcortical inhibitory signal for behavioral arrest in the thalamus. Nature Neuroscience. 18(4). 562–568. 54 indexed citations
5.
Soós, Judit, József I. Engelhardt, László Siklós, László Havas, & Katalin Majtényi. (2004). The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease. Neuroreport. 15(11). 1715–1718. 67 indexed citations
6.
Thomas, Neil, Katalin Majtényi, László Havas, et al.. (2003). Regio entorhinalis in Schizophrenia: More Evidence for Migrational Disturbances and Suggestions for a New Biological Hypothesis. Pharmacopsychiatry. 36. 158–161. 22 indexed citations
7.
Wirths, Oliver, Svenja Weickert, Katalin Majtényi, et al.. (2000). Lewy body variant of Alzheimerʼs disease. Neuroreport. 11(17). 3737–3741. 41 indexed citations
8.
Bayer, Thomas A., Rolf Buslei, László Havas, & Peter Falkai. (1999). Evidence for activation of microglia in patients with psychiatric illnesses. Neuroscience Letters. 271(2). 126–128. 248 indexed citations
9.
Bayer, Thomas A., Pekka Jäkälä, Tobias Hartmann, et al.. (1999). α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores. Neuroscience Letters. 266(3). 213–216. 75 indexed citations
10.
Rossi, Marco, et al.. (1991). Mononuclear Cell Infiltrate and HLA-Dr Expression in Intra- and Extradural Secondary Carcinomas. Pathology - Research and Practice. 187(1). 55–61. 3 indexed citations
11.
Rossi, Marco, et al.. (1991). HLA-Dr Expression by Tumor Cells Compared with Survival in High Grade Astrocytomas. Tumori Journal. 77(2). 122–125. 7 indexed citations
12.
Havas, László. (1990). Schemata und Wahrheit in der Darstellung der spätrepublikanischen politischen Ereignisse. Klio. 72(72). 216–224. 1 indexed citations
13.
Esiri, M M, et al.. (1990). Mononuclear cell infiltrate, HLA-Dr expression and proliferation in 37 acoustic schwannomas.. PubMed. 5(4). 427–32. 12 indexed citations
14.
Kuhn, H. Georg, Peter Angehrn, & László Havas. (1986). Autoradiographic Evidence for Penetration of <sup>3</sup>H-Ceftriaxone (Rocephin®) into Cells of Spleen, Liver and Kidney of Mice. Chemotherapy. 32(2). 102–112. 13 indexed citations
15.
Havas, László. (1986). [Brain and liver damage and other alcoholism-associated disorders (20 years of pathological experience)].. PubMed. 127(29). 1739–46.
16.
Havas, László. (1984). Zur Geschichtskonzeption des Florus. Klio. 66(66). 590–598.
17.
Tóth, Éva, et al.. (1981). [Gastric amyloidosis simulating a malignant tumor].. PubMed. 122(16). 958–60. 1 indexed citations
18.
Allen, John G., et al.. (1979). Phosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humans. Antimicrobial Agents and Chemotherapy. 16(3). 306–313. 22 indexed citations
20.
Havas, László, et al.. (1951). The Oncological Aspect of the "Immunity" of Colchicum to Colchicine. Science. 114(2956). 208–210. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026